Results 311 to 320 of about 645,099 (360)
Some of the next articles are maybe not open access.
Transplantation Proceedings, 2016
In this study, we retrospectively analyzed the recurrence of hepatitis B virus (HBV) and hepatitis D virus (HDV) infection after liver transplantation for HBV and HBV+HDV co-infection.Data from patients infected with HBV and HBV+HDV who underwent liver transplantation between March 2003 and June 2013 at the Liver Transplantation Institute of Inonu ...
B, Adil +8 more
openaire +2 more sources
In this study, we retrospectively analyzed the recurrence of hepatitis B virus (HBV) and hepatitis D virus (HDV) infection after liver transplantation for HBV and HBV+HDV co-infection.Data from patients infected with HBV and HBV+HDV who underwent liver transplantation between March 2003 and June 2013 at the Liver Transplantation Institute of Inonu ...
B, Adil +8 more
openaire +2 more sources
Hepatitis B Virus DNA in Fulminant Hepatitis B
Annals of Internal Medicine, 1986Excerpt Patients with fulminant hepatitis B have hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) detected for shorter periods than do patients with nonfulminant infections, an...
de cock, km +3 more
openaire +2 more sources
Hepatitis B virus and hepatitis delta virus
1992Hepatitis B virus (HBV) may cause acute and chronic infection of the liver. Acute hepatitis B infection may cause serious icteric hepatitis or even fulminant hepatitis, though the infection may be anicteric and asymptomatic in a high proportion of cases.
T J, Harrison, G M, Dusheiko
openaire +2 more sources
Hepatitis B virus and myocarditis
Human Pathology, 1984Myocarditis may be a serious extrahepatic complication of hepatitis. In this fatal case of serologically documented hepatitis B viral hepatitis, acute myocarditis was present, with histologic features consistent with a viral pathogenesis. Hepatitis B surface antigen was demonstrated by immunoperoxidase methods in small intramyocardial vessels ...
P C, Ursell +5 more
openaire +2 more sources
Nature Reviews Disease Primers, 2018
Hepatitis B virus (HBV) is a hepatotropic virus that can establish a persistent and chronic infection in humans through immune anergy. Currently, 3.5% of the global population is chronically infected with HBV, although the incidence of HBV infections is decreasing owing to vaccination and, to a lesser extent, the use of antiviral therapy to reduce the ...
Man-Fung, Yuen +7 more
openaire +4 more sources
Hepatitis B virus (HBV) is a hepatotropic virus that can establish a persistent and chronic infection in humans through immune anergy. Currently, 3.5% of the global population is chronically infected with HBV, although the incidence of HBV infections is decreasing owing to vaccination and, to a lesser extent, the use of antiviral therapy to reduce the ...
Man-Fung, Yuen +7 more
openaire +4 more sources
Vaccine, 2005
Eight genotypes of hepatitis B virus (A-H) are currently recognized, and subgenotypes have recently been described in four of these genotypes (A, B, C and F). The genotypes show a distinct geographical distribution between and even within regions, and are proving to be an invaluable tool in tracing the molecular evolution and patterns and modes of ...
Kramvis, Anna +2 more
openaire +3 more sources
Eight genotypes of hepatitis B virus (A-H) are currently recognized, and subgenotypes have recently been described in four of these genotypes (A, B, C and F). The genotypes show a distinct geographical distribution between and even within regions, and are proving to be an invaluable tool in tracing the molecular evolution and patterns and modes of ...
Kramvis, Anna +2 more
openaire +3 more sources
Trends in Microbiology, 1993
Hepatitis B virus (HBV) is the causative agent of B-type hepatitis in humans and the prototypic member of the hepadnaviruses. It is a small enveloped DNA virus that replicates via reverse transcription. Although hepadnaviruses are similar to retroviruses in basic life cycle and genome organization, recent studies have revealed several unique ...
M, Nassal, H, Schaller
openaire +2 more sources
Hepatitis B virus (HBV) is the causative agent of B-type hepatitis in humans and the prototypic member of the hepadnaviruses. It is a small enveloped DNA virus that replicates via reverse transcription. Although hepadnaviruses are similar to retroviruses in basic life cycle and genome organization, recent studies have revealed several unique ...
M, Nassal, H, Schaller
openaire +2 more sources
Nature Reviews Gastroenterology & Hepatology, 2009
HBV replicates through reverse transcription of an RNA intermediate; the inherent lack of proofreading causes a high mutation frequency. Mutations in the precore and core promoter regions that abolish or reduce the production of hepatitis B e antigen occur most commonly.
Watcharasak, Chotiyaputta, Anna S F, Lok
openaire +2 more sources
HBV replicates through reverse transcription of an RNA intermediate; the inherent lack of proofreading causes a high mutation frequency. Mutations in the precore and core promoter regions that abolish or reduce the production of hepatitis B e antigen occur most commonly.
Watcharasak, Chotiyaputta, Anna S F, Lok
openaire +2 more sources
The Nurse Practitioner, 1983
Hepatitis B is a major public health problem. Complications of the disease can include a carrier state, chronic active hepatitis, cirrhosis and hepatocellular carcinoma. The development of hepatitis B virus vaccine has made active immunization against HBV possible.
openaire +2 more sources
Hepatitis B is a major public health problem. Complications of the disease can include a carrier state, chronic active hepatitis, cirrhosis and hepatocellular carcinoma. The development of hepatitis B virus vaccine has made active immunization against HBV possible.
openaire +2 more sources
The Lancet, 2009
Since the introduction of the hepatitis B vaccine and other preventive measures, the worldwide prevalence of hepatitis B infection has fallen. However, chronic infection remains a challenging global health problem, with more than 350 million people chronically infected and at risk of hepatic decompensation, cirrhosis, and hepatocellular carcinoma.
Yun-Fan, Liaw, Chia-Ming, Chu
openaire +2 more sources
Since the introduction of the hepatitis B vaccine and other preventive measures, the worldwide prevalence of hepatitis B infection has fallen. However, chronic infection remains a challenging global health problem, with more than 350 million people chronically infected and at risk of hepatic decompensation, cirrhosis, and hepatocellular carcinoma.
Yun-Fan, Liaw, Chia-Ming, Chu
openaire +2 more sources